Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 10 | 2025 | 122 | 4.090 |
Why?
|
| Air Pollution | 10 | 2024 | 77 | 2.960 |
Why?
|
| Maternal Exposure | 11 | 2025 | 144 | 2.750 |
Why?
|
| Environmental Exposure | 10 | 2024 | 260 | 2.750 |
Why?
|
| Particulate Matter | 12 | 2025 | 90 | 2.520 |
Why?
|
| Fluorocarbons | 7 | 2018 | 61 | 2.270 |
Why?
|
| DDT | 3 | 2020 | 6 | 1.560 |
Why?
|
| Birth Weight | 6 | 2025 | 337 | 1.530 |
Why?
|
| Insecticides | 3 | 2020 | 46 | 1.510 |
Why?
|
| Environmental Pollutants | 5 | 2018 | 73 | 1.460 |
Why?
|
| Pregnancy | 32 | 2025 | 7395 | 1.390 |
Why?
|
| Occupational Exposure | 6 | 2022 | 132 | 1.270 |
Why?
|
| Premature Birth | 4 | 2020 | 404 | 1.260 |
Why?
|
| Oil and Gas Industry | 3 | 2018 | 5 | 1.140 |
Why?
|
| Air Pollution, Indoor | 3 | 2018 | 81 | 1.040 |
Why?
|
| Alkanesulfonic Acids | 5 | 2018 | 11 | 1.020 |
Why?
|
| Natural Gas | 3 | 2022 | 5 | 0.920 |
Why?
|
| Nitrogen Dioxide | 5 | 2022 | 25 | 0.910 |
Why?
|
| Metals, Heavy | 3 | 2021 | 22 | 0.860 |
Why?
|
| Texas | 20 | 2025 | 3563 | 0.850 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2024 | 228 | 0.780 |
Why?
|
| Environmental Monitoring | 6 | 2023 | 98 | 0.780 |
Why?
|
| Caprylates | 2 | 2012 | 13 | 0.750 |
Why?
|
| Oil and Gas Fields | 2 | 2019 | 9 | 0.740 |
Why?
|
| Female | 49 | 2025 | 68483 | 0.720 |
Why?
|
| Norway | 9 | 2018 | 29 | 0.720 |
Why?
|
| Ozone | 2 | 2019 | 20 | 0.720 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 3 | 2020 | 14 | 0.710 |
Why?
|
| Parity | 3 | 2016 | 81 | 0.700 |
Why?
|
| Cooking | 2 | 2018 | 37 | 0.690 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 231 | 0.680 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2016 | 43 | 0.670 |
Why?
|
| Hydraulic Fracking | 1 | 2020 | 1 | 0.670 |
Why?
|
| Pregnancy Outcome | 3 | 2020 | 623 | 0.670 |
Why?
|
| Adult | 30 | 2025 | 30435 | 0.620 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2019 | 34 | 0.610 |
Why?
|
| Fertility | 2 | 2012 | 251 | 0.600 |
Why?
|
| Swine | 5 | 2025 | 1173 | 0.560 |
Why?
|
| Residence Characteristics | 3 | 2020 | 285 | 0.560 |
Why?
|
| Bayes Theorem | 3 | 2024 | 287 | 0.550 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 39 | 0.550 |
Why?
|
| Arsenic | 2 | 2020 | 36 | 0.540 |
Why?
|
| Humans | 55 | 2025 | 127095 | 0.540 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 486 | 0.530 |
Why?
|
| South Africa | 4 | 2020 | 99 | 0.520 |
Why?
|
| Time-to-Pregnancy | 1 | 2016 | 2 | 0.510 |
Why?
|
| Zygote | 1 | 2016 | 28 | 0.500 |
Why?
|
| Maternal Age | 1 | 2016 | 129 | 0.490 |
Why?
|
| Gene Targeting | 1 | 2016 | 167 | 0.480 |
Why?
|
| Inflammation | 3 | 2022 | 1433 | 0.460 |
Why?
|
| Embryonic Development | 1 | 2016 | 220 | 0.440 |
Why?
|
| Reproductive Health | 1 | 2015 | 47 | 0.440 |
Why?
|
| Pesticides | 2 | 2022 | 28 | 0.440 |
Why?
|
| Young Adult | 11 | 2019 | 9694 | 0.440 |
Why?
|
| Sulfonamides | 1 | 2016 | 280 | 0.430 |
Why?
|
| Mental Disorders | 1 | 2022 | 862 | 0.430 |
Why?
|
| Stillbirth | 3 | 2019 | 98 | 0.430 |
Why?
|
| Benzene | 3 | 2020 | 24 | 0.420 |
Why?
|
| Occupational Diseases | 2 | 2014 | 79 | 0.410 |
Why?
|
| Swine Diseases | 2 | 2024 | 40 | 0.400 |
Why?
|
| Noise, Occupational | 3 | 2019 | 3 | 0.390 |
Why?
|
| Fetal Development | 3 | 2022 | 126 | 0.390 |
Why?
|
| Asthma | 2 | 2019 | 896 | 0.380 |
Why?
|
| Fetal Macrosomia | 1 | 2012 | 17 | 0.380 |
Why?
|
| Life Style | 1 | 2015 | 432 | 0.370 |
Why?
|
| Rural Population | 3 | 2021 | 247 | 0.370 |
Why?
|
| Endocrine Disruptors | 2 | 2022 | 55 | 0.350 |
Why?
|
| Volatile Organic Compounds | 2 | 2022 | 11 | 0.340 |
Why?
|
| Cohort Studies | 9 | 2022 | 4972 | 0.340 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 77 | 0.330 |
Why?
|
| Agrochemicals | 1 | 2010 | 13 | 0.330 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 865 | 0.320 |
Why?
|
| Infant, Newborn | 8 | 2025 | 8350 | 0.320 |
Why?
|
| Agriculture | 2 | 2007 | 30 | 0.320 |
Why?
|
| Odds Ratio | 5 | 2016 | 1216 | 0.310 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2010 | 52 | 0.310 |
Why?
|
| Disasters | 2 | 2021 | 100 | 0.300 |
Why?
|
| Logistic Models | 5 | 2017 | 1788 | 0.290 |
Why?
|
| CRISPR-Cas Systems | 2 | 2024 | 277 | 0.280 |
Why?
|
| Gestational Age | 3 | 2022 | 1186 | 0.280 |
Why?
|
| Biomarkers | 6 | 2020 | 3233 | 0.270 |
Why?
|
| Tinnitus | 2 | 2019 | 23 | 0.270 |
Why?
|
| Prevalence | 5 | 2021 | 2612 | 0.270 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 143 | 0.260 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 381 | 0.250 |
Why?
|
| Pilot Projects | 5 | 2022 | 1399 | 0.240 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2006 | 15 | 0.240 |
Why?
|
| Transients and Migrants | 1 | 2006 | 28 | 0.240 |
Why?
|
| Occupational Health | 1 | 2006 | 46 | 0.240 |
Why?
|
| Hearing Loss | 2 | 2019 | 199 | 0.230 |
Why?
|
| Self Report | 2 | 2020 | 538 | 0.230 |
Why?
|
| Housing | 2 | 2016 | 71 | 0.220 |
Why?
|
| Bronchoscopy | 1 | 2025 | 179 | 0.220 |
Why?
|
| Case-Control Studies | 5 | 2019 | 3322 | 0.220 |
Why?
|
| Mothers | 2 | 2013 | 363 | 0.210 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 57 | 0.210 |
Why?
|
| Exercise | 2 | 2020 | 844 | 0.210 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2024 | 122 | 0.210 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2016 | 79 | 0.210 |
Why?
|
| Serine Endopeptidases | 1 | 2024 | 191 | 0.200 |
Why?
|
| Industry | 2 | 2021 | 29 | 0.200 |
Why?
|
| Solvents | 2 | 2022 | 43 | 0.200 |
Why?
|
| Military Personnel | 2 | 2016 | 208 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 795 | 0.190 |
Why?
|
| Water Wells | 1 | 2022 | 1 | 0.190 |
Why?
|
| Urban Population | 3 | 2021 | 275 | 0.190 |
Why?
|
| Fetal Weight | 1 | 2022 | 71 | 0.190 |
Why?
|
| Picornaviridae | 1 | 2022 | 18 | 0.190 |
Why?
|
| Health Status Disparities | 1 | 2025 | 267 | 0.180 |
Why?
|
| Gene Editing | 1 | 2024 | 197 | 0.180 |
Why?
|
| Data Collection | 1 | 2023 | 370 | 0.180 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.180 |
Why?
|
| Child, Preschool | 4 | 2024 | 14423 | 0.180 |
Why?
|
| Picornaviridae Infections | 1 | 2022 | 50 | 0.180 |
Why?
|
| Virus Replication | 1 | 2024 | 593 | 0.180 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2022 | 68 | 0.180 |
Why?
|
| Seasons | 1 | 2023 | 318 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 788 | 0.180 |
Why?
|
| Cognition | 2 | 2024 | 785 | 0.180 |
Why?
|
| Canada | 1 | 2022 | 315 | 0.170 |
Why?
|
| Deer | 1 | 2021 | 14 | 0.170 |
Why?
|
| Animals, Genetically Modified | 2 | 2025 | 325 | 0.170 |
Why?
|
| Child | 7 | 2024 | 25228 | 0.170 |
Why?
|
| British Columbia | 1 | 2020 | 8 | 0.170 |
Why?
|
| Disaster Planning | 1 | 2021 | 61 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1340 | 0.170 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2020 | 163 | 0.160 |
Why?
|
| Fires | 1 | 2020 | 9 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2025 | 17065 | 0.160 |
Why?
|
| Abruptio Placentae | 1 | 2019 | 14 | 0.150 |
Why?
|
| Informal Sector | 1 | 2019 | 1 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 992 | 0.150 |
Why?
|
| Lipids | 2 | 2013 | 546 | 0.150 |
Why?
|
| Smoking | 2 | 2016 | 904 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 881 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 105 | 0.150 |
Why?
|
| Temperature | 1 | 2019 | 288 | 0.140 |
Why?
|
| Hearing Loss, Noise-Induced | 2 | 2016 | 5 | 0.140 |
Why?
|
| Biomass | 1 | 2018 | 25 | 0.140 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2018 | 50 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4446 | 0.140 |
Why?
|
| Menstrual Cycle | 1 | 2018 | 34 | 0.140 |
Why?
|
| Particle Size | 1 | 2018 | 133 | 0.140 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 34 | 0.140 |
Why?
|
| Linear Models | 2 | 2017 | 687 | 0.140 |
Why?
|
| Water Quality | 1 | 2017 | 8 | 0.140 |
Why?
|
| Water Microbiology | 1 | 2017 | 26 | 0.140 |
Why?
|
| Menstruation | 1 | 2017 | 26 | 0.140 |
Why?
|
| Groundwater | 1 | 2017 | 10 | 0.140 |
Why?
|
| Animals | 8 | 2025 | 33154 | 0.140 |
Why?
|
| Geography, Medical | 1 | 2017 | 17 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 2024 | 866 | 0.130 |
Why?
|
| Mexican Americans | 1 | 2018 | 165 | 0.130 |
Why?
|
| Sex Ratio | 1 | 2016 | 11 | 0.130 |
Why?
|
| Aged | 3 | 2020 | 20431 | 0.130 |
Why?
|
| Mental Health | 1 | 2020 | 364 | 0.130 |
Why?
|
| Heating | 1 | 2016 | 1 | 0.130 |
Why?
|
| Blastocyst | 1 | 2016 | 77 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 3933 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2022 | 6242 | 0.120 |
Why?
|
| United States | 7 | 2019 | 11386 | 0.120 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 31 | 0.120 |
Why?
|
| Risk Factors | 7 | 2019 | 10610 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 1494 | 0.120 |
Why?
|
| Marijuana Abuse | 1 | 2016 | 53 | 0.120 |
Why?
|
| Gravidity | 1 | 2015 | 12 | 0.120 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 231 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2017 | 473 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 349 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 3680 | 0.110 |
Why?
|
| Pesticide Residues | 1 | 2014 | 4 | 0.110 |
Why?
|
| Adolescent | 5 | 2018 | 20082 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2017 | 798 | 0.110 |
Why?
|
| Middle Aged | 6 | 2019 | 27801 | 0.100 |
Why?
|
| Mosquito Control | 1 | 2014 | 31 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2016 | 283 | 0.100 |
Why?
|
| Bacteria | 1 | 2017 | 515 | 0.100 |
Why?
|
| Infant | 3 | 2024 | 12784 | 0.100 |
Why?
|
| Malaria | 1 | 2014 | 97 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2018 | 547 | 0.100 |
Why?
|
| Seafood | 1 | 2012 | 10 | 0.090 |
Why?
|
| Body Burden | 1 | 2012 | 3 | 0.090 |
Why?
|
| Food Contamination | 1 | 2012 | 27 | 0.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2012 | 56 | 0.090 |
Why?
|
| Male | 9 | 2021 | 62658 | 0.090 |
Why?
|
| Neoplasms | 1 | 2007 | 2856 | 0.090 |
Why?
|
| Diet Surveys | 1 | 2012 | 100 | 0.090 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2012 | 56 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2012 | 232 | 0.090 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2011 | 18 | 0.090 |
Why?
|
| Hazardous Substances | 1 | 2011 | 17 | 0.090 |
Why?
|
| Progestins | 1 | 2011 | 40 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2011 | 81 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2011 | 47 | 0.080 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 66 | 0.080 |
Why?
|
| Contraceptive Agents, Female | 1 | 2011 | 32 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2011 | 267 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2016 | 1651 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 429 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 221 | 0.080 |
Why?
|
| Age Factors | 1 | 2016 | 2799 | 0.080 |
Why?
|
| Pregnancy Trimester, First | 2 | 2020 | 118 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1302 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 442 | 0.080 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 345 | 0.070 |
Why?
|
| United States Environmental Protection Agency | 1 | 2008 | 7 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2011 | 279 | 0.070 |
Why?
|
| Social Class | 1 | 2008 | 206 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1561 | 0.060 |
Why?
|
| Rural Health | 1 | 2007 | 41 | 0.060 |
Why?
|
| Diet | 1 | 2013 | 1095 | 0.060 |
Why?
|
| United States Department of Defense | 2 | 2016 | 9 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2021 | 3588 | 0.060 |
Why?
|
| Spouses | 1 | 2006 | 70 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2025 | 169 | 0.060 |
Why?
|
| Virus Shedding | 1 | 2024 | 75 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 192 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2024 | 130 | 0.050 |
Why?
|
| Heart Valves | 1 | 2024 | 52 | 0.050 |
Why?
|
| Influenza A virus | 1 | 2024 | 148 | 0.050 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2024 | 185 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2586 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 452 | 0.050 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2022 | 16 | 0.050 |
Why?
|
| Anodontia | 1 | 2022 | 30 | 0.050 |
Why?
|
| Receptors, Peptide | 1 | 2022 | 54 | 0.050 |
Why?
|
| Alopecia | 1 | 2022 | 40 | 0.050 |
Why?
|
| Soil | 1 | 2021 | 73 | 0.040 |
Why?
|
| China | 1 | 2021 | 277 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2022 | 181 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 2071 | 0.040 |
Why?
|
| Incidence | 1 | 2008 | 3259 | 0.040 |
Why?
|
| Spain | 1 | 2020 | 60 | 0.040 |
Why?
|
| Conservation of Natural Resources | 1 | 2020 | 24 | 0.040 |
Why?
|
| Cadmium | 1 | 2020 | 28 | 0.040 |
Why?
|
| Soot | 1 | 2020 | 14 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2022 | 200 | 0.040 |
Why?
|
| Weather | 1 | 2019 | 16 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 166 | 0.040 |
Why?
|
| Environment | 1 | 2020 | 150 | 0.040 |
Why?
|
| Toluene | 1 | 2019 | 10 | 0.040 |
Why?
|
| Urban Health | 1 | 2019 | 84 | 0.040 |
Why?
|
| Benzene Derivatives | 1 | 2019 | 20 | 0.040 |
Why?
|
| Metals | 1 | 2019 | 56 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 255 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 316 | 0.040 |
Why?
|
| Hydrocarbons | 1 | 2017 | 8 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2017 | 58 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 301 | 0.030 |
Why?
|
| Risk | 1 | 2019 | 735 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2016 | 50 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 154 | 0.030 |
Why?
|
| Premenopause | 1 | 2015 | 36 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 202 | 0.030 |
Why?
|
| Women's Health | 1 | 2016 | 138 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 1537 | 0.030 |
Why?
|
| Breast | 1 | 2015 | 206 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 787 | 0.020 |
Why?
|
| Phenotype | 1 | 2022 | 4306 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 1291 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2014 | 391 | 0.020 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2011 | 16 | 0.020 |
Why?
|
| Cholesterol | 1 | 2013 | 536 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 692 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2011 | 79 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5148 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 4799 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12567 | 0.010 |
Why?
|